Author details

Full Name

Jeannette T Bensen

Affiliation

ORCID

Career Start Year

1985

Papers

144

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38064200	The motivation and process for developing a consortium-wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care.	Clin Transl Sci	2024
36980585	Interactions of SNPs in Folate Metabolism Related Genes on Prostate Cancer Aggressiveness in European Americans and African Americans.		2023
36310386	The Burden of COVID-19 on Caregivers of Children with Suspected Genetic Conditions: A Therapeutic Odyssey.	Phys Occup Ther Pediatr	2023
36251841	Patient-Reported Sexual Function Among Young Adult Cancer Survivors.	Journal of Adolescent and Young Adult Oncology	2023
36341765	Conducting clinical genomics research during the COVID-19 pandemic: Lessons learned from the CSER consortium experience.	Am J Med Genet A	2023
36063402	Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.	Prostate	2023
37945903	Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.	Nat Genet	2023
37919455	The impact of marital status on tumor aggressiveness, treatment, and screening among black and white men diagnosed with prostate cancer.		2023
36567057	Lessons learned while starting multi-institutional genetics research in diverse populations: A report from the Clinical Sequencing Evidence-Generating Research (CSER) consortium.	Contemp Clin Trials	2023
36872133	Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.	Eur Urol	2023
36689884	Question prompt lists and caregiver question asking in pediatric specialty appointments: A randomized controlled trial.	Patient Educ Couns	2023
35201637	Neighborhood deprivation and risk of mortality among men with prostate cancer: Findings from a long-term follow-up study.	Prostate	2022
35707062	Lessons learned and recommendations for data coordination in collaborative research: The CSER consortium experience.	HGG Adv	2022
35880605	Using health insurance claims data to assess long-term disease progression in a prostate cancer cohort.	Prostate	2022
35554533	Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.	Hum Mol Genet	2022
36067243	Patients With Advanced Cancer and Minor Children: An Exploratory Study of Health-Related Quality of Life and Satisfaction With Care.	Oncology Nursing Forum	2022
35405498	Characteristics and outcomes associated with anxiety and depression in a head and neck cancer survivorship cohort.	Am J Otolaryngol	2022
34127801	Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.	Prostate Cancer Prostatic Dis	2022
35320830	Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP).	Cancer Causes and Control	2022
34793605	Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.	Head Neck	2022
35034852	Testing and extending strategies for identifying genetic disease-related encounters in pediatric patients.	Genet Med	2022
35031163	A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.	Eur Urol	2022
34926976	Evaluation of Patient-Reported Delays and Affordability-Related Barriers to Care in Head and Neck Cancer.	OTO Open	2021
34127041	Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.	Trials	2021
34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Nat Commun	2021
33473200	Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
33619025	Differential Associations of SLCO Transporters with Prostate Cancer Aggressiveness between African Americans and European Americans.	Cancer Epidemiology Biomarkers and Prevention	2021
33769540	Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry.	J Natl Cancer Inst	2021
32930425	African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.	Int J Cancer	2021
32960377	Genetic variants in anti-MÃ¼llerian hormone-related genes and breast cancer risk: results from the AMBER consortium.	Breast Cancer Res Treat	2021
33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
33007922	Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status.	Biomolecules	2020
31837003	Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer.	International Journal of Cancer	2020
32409115	A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.	Eur Urol	2020
33198142	Understanding the Relationship between Environmental Arsenic and Prostate Cancer Aggressiveness among African-American and European-American Men in North Carolina.	International Journal of Environmental Research and Public Health	2020
31246284	Prevalence and predictors of probable depression in prostate cancer survivors.	Cancer	2019
30268488	Dietary patterns based on the Mediterranean diet and DASH diet are inversely associated with high aggressive prostate cancer in PCaP.	Annals of Epidemiology	2019
30484012	Frailty and health-related quality of life in older women with breast cancer.	Supportive Care in Cancer	2019
30327876	Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients.	Cancer Chemotherapy and Pharmacology	2019
30567620	Tea consumption and oxidative stress: a cross-sectional analysis of 889 premenopausal women from the Sister Study.	British Journal of Nutrition	2019
31077420	Association among plasma 1,25(OH) D, ratio of 1,25(OH) D to 25(OH)D, and prostate cancer aggressiveness.	Prostate	2019
31106980	Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors.	Cancer Medicine	2019
29155338	Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life.	J Urol	2018
30267174	The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.	Cancer Causes and Control	2018
30355027	Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance.	J Oncol Pract	2018
30397198	Germline variation at 8q24 and prostate cancer risk in men of European ancestry.	Nat Commun	2018
29925318	Modelling attrition and nonparticipation in a longitudinal study of prostate cancer.	BMC Medical Research Methodology	2018
29871690	A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.	Breast Cancer Res	2018
30193136	The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.	Am J Hum Genet	2018
29722851	Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).	American Journal of Clinical Nutrition	2018